Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

5.08
Delayed Data
As of Jan 20
 -0.17 / -3.24%
Today’s Change
5.05
Today|||52-Week Range
8.06
-0.39%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close5.25
Today’s open5.30
Day’s range5.08 - 5.30
Volume8,538
Average volume (3 months)9,196
Market cap$129.4M
Dividend yield--
Data as of 3:55pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...+0.05+2.02%
VBLTVascular Biogenics L...0.000.00%
ADVMAdverum Biotechnolog...0.000.00%
VBIVVBI Vaccines Inc+0.07+2.07%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Tel Aviv

Forecasts


Search for Jobs